FDA-approved : It is FDA-approved for type 2 diabetes, chronic weight management, and reducing the risk of serious heart problems in adults with obesity or overweight ensuring safety and efficacy for its intended use
Weeks to months, and individual responses vary
Abbasinejad and the team explain that Wegovy is a GLP-1 medication designed to gradually support weight loss rather than produce immediate results
Beyond the contraindication question, hypothyroidism is a common and frequently underdiagnosed condition that causes weight gain, fatigue, and metabolic slowdown symptoms that may be mistakenly attributed to poor GLP-1 response if thyroid dysfunction is not identified and treated
GLP-1, or glucagon-like peptide-1, is a hormone released in the intestines in response to food intake
Step-by-Step Mechanism of Action GLP1 receptor activation Semaglutide binds to GLP1 receptors on pancreatic cells and brain centers, mimicking endogenous GLP1